Shopping Cart
Remove All
Your shopping cart is currently empty
KBP-7018 is a potent and highly selective tyrosine kinase inhibitor that simultaneously targets three key fibrotic-associated kinases, including c-KIT, RET, and PDGFR, with IC50 values of 10 nM, 7.6 nM, and 25 nM respectively, and is therefore widely applicable for mechanistic research into fibrotic signaling pathways, kinase-driven disease progression, and pharmacological intervention strategies aimed at modulating aberrant tyrosine kinase activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $333 | - | In Stock | |
| 5 mg | $790 | - | In Stock | |
| 10 mg | $1,120 | - | In Stock | |
| 25 mg | $1,670 | - | In Stock |
| Description | KBP-7018 is a potent and highly selective tyrosine kinase inhibitor that simultaneously targets three key fibrotic-associated kinases, including c-KIT, RET, and PDGFR, with IC50 values of 10 nM, 7.6 nM, and 25 nM respectively, and is therefore widely applicable for mechanistic research into fibrotic signaling pathways, kinase-driven disease progression, and pharmacological intervention strategies aimed at modulating aberrant tyrosine kinase activity. |
| Targets&IC50 | RET:7.6 nM, PDGFR:25 nM, c-KIT:10 nM |
| In vivo | Method: KBP-7018 was administered orally at 10, 30, or 100 mg/kg once daily in a bleomycin-induced pulmonary fibrosis mouse model. Result: KBP-7018 improved 28-day survival in a dose-dependent manner and showed greater efficacy than nintedanib[1]. |
| Synonyms | KBP-7018, KBP7018, KBP 7018 |
| Molecular Weight | 538.59 |
| Formula | C31H30N4O5 |
| Cas No. | 1613437-66-3 |
| Smiles | C(\NC=1C=C2C(=CC1)N(C(CN3CCOCC3)=O)CC2)(=C\4/C=5C(NC4=O)=CC(C(OC)=O)=CC5)/C6=CC=CC=C6 |
| Relative Density. | 1.346 g/cm3 (Predicted) |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.